PMC:7228307 / 60027-60294
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1221","span":{"begin":43,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A1221","pred":"tao:has_database_id","subj":"1221","obj":"MESH:D011134"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T455","span":{"begin":28,"end":31},"obj":"Body_part"}],"attributes":[{"id":"A455","pred":"fma_id","subj":"T455","obj":"http://purl.org/sig/ont/fma/fma62872"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T992","span":{"begin":32,"end":34},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T993","span":{"begin":50,"end":53},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T994","span":{"begin":61,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T255","span":{"begin":136,"end":146},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T413","span":{"begin":0,"end":7},"obj":"RB"},{"id":"T414","span":{"begin":7,"end":8},"obj":"-COMMA-"},{"id":"T415","span":{"begin":9,"end":20},"obj":"NN"},{"id":"T416","span":{"begin":21,"end":23},"obj":"IN"},{"id":"T417","span":{"begin":24,"end":27},"obj":"DT"},{"id":"T418","span":{"begin":28,"end":31},"obj":"NN"},{"id":"T419","span":{"begin":32,"end":34},"obj":"NN"},{"id":"T420","span":{"begin":35,"end":38},"obj":"CC"},{"id":"T421","span":{"begin":39,"end":42},"obj":"PRP-DOLLAR-"},{"id":"T422","span":{"begin":43,"end":49},"obj":"NN"},{"id":"T423","span":{"begin":50,"end":53},"obj":"VBZ"},{"id":"T424","span":{"begin":54,"end":60},"obj":"VBN"},{"id":"T425","span":{"begin":61,"end":62},"obj":"DT"},{"id":"T426","span":{"begin":63,"end":69},"obj":"JJ"},{"id":"T427","span":{"begin":70,"end":73},"obj":"CC"},{"id":"T428","span":{"begin":74,"end":83},"obj":"JJ"},{"id":"T429","span":{"begin":84,"end":92},"obj":"NN"},{"id":"T430","span":{"begin":93,"end":96},"obj":"IN"},{"id":"T431","span":{"begin":97,"end":107},"obj":"VBG"},{"id":"T432","span":{"begin":108,"end":111},"obj":"DT"},{"id":"T433","span":{"begin":112,"end":120},"obj":"JJ"},{"id":"T434","span":{"begin":121,"end":134},"obj":"NN"},{"id":"T435","span":{"begin":134,"end":135},"obj":"-COMMA-"},{"id":"T436","span":{"begin":136,"end":146},"obj":"JJ"},{"id":"T437","span":{"begin":147,"end":158},"obj":"NN"},{"id":"T438","span":{"begin":159,"end":162},"obj":"CC"},{"id":"T439","span":{"begin":163,"end":169},"obj":"NN"},{"id":"T440","span":{"begin":170,"end":172},"obj":"IN"},{"id":"T441","span":{"begin":173,"end":184},"obj":"JJ"},{"id":"T442","span":{"begin":185,"end":189},"obj":"NNS"},{"id":"T443","span":{"begin":190,"end":193},"obj":"CC"},{"id":"T444","span":{"begin":194,"end":196},"obj":"VBZ"},{"id":"T445","span":{"begin":197,"end":199},"obj":"DT"},{"id":"T446","span":{"begin":200,"end":208},"obj":"VBG"},{"id":"T447","span":{"begin":209,"end":216},"obj":"NN"},{"id":"T448","span":{"begin":217,"end":219},"obj":"TO"},{"id":"T449","span":{"begin":220,"end":223},"obj":"DT"},{"id":"T450","span":{"begin":224,"end":235},"obj":"NN"},{"id":"T451","span":{"begin":236,"end":238},"obj":"IN"},{"id":"T452","span":{"begin":239,"end":242},"obj":"DT"},{"id":"T453","span":{"begin":243,"end":253},"obj":"NN"},{"id":"T454","span":{"begin":254,"end":266},"obj":"NNS"}],"relations":[{"id":"R423","pred":"arg1Of","subj":"T443","obj":"T413"},{"id":"R424","pred":"arg1Of","subj":"T443","obj":"T414"},{"id":"R425","pred":"arg1Of","subj":"T415","obj":"T416"},{"id":"R426","pred":"arg2Of","subj":"T420","obj":"T416"},{"id":"R427","pred":"arg1Of","subj":"T419","obj":"T417"},{"id":"R428","pred":"arg1Of","subj":"T419","obj":"T418"},{"id":"R429","pred":"arg1Of","subj":"T419","obj":"T420"},{"id":"R430","pred":"arg2Of","subj":"T422","obj":"T420"},{"id":"R431","pred":"arg1Of","subj":"T422","obj":"T421"},{"id":"R432","pred":"arg1Of","subj":"T415","obj":"T423"},{"id":"R433","pred":"arg2Of","subj":"T424","obj":"T423"},{"id":"R434","pred":"arg1Of","subj":"T415","obj":"T424"},{"id":"R435","pred":"arg2Of","subj":"T435","obj":"T424"},{"id":"R436","pred":"arg1Of","subj":"T429","obj":"T425"},{"id":"R437","pred":"arg1Of","subj":"T429","obj":"T426"},{"id":"R438","pred":"arg1Of","subj":"T426","obj":"T427"},{"id":"R439","pred":"arg2Of","subj":"T428","obj":"T427"},{"id":"R440","pred":"arg1Of","subj":"T429","obj":"T428"},{"id":"R441","pred":"arg1Of","subj":"T429","obj":"T430"},{"id":"R442","pred":"arg2Of","subj":"T431","obj":"T430"},{"id":"R443","pred":"arg2Of","subj":"T434","obj":"T431"},{"id":"R444","pred":"arg1Of","subj":"T434","obj":"T432"},{"id":"R445","pred":"arg1Of","subj":"T434","obj":"T433"},{"id":"R446","pred":"arg1Of","subj":"T429","obj":"T435"},{"id":"R447","pred":"arg2Of","subj":"T438","obj":"T435"},{"id":"R448","pred":"arg1Of","subj":"T438","obj":"T436"},{"id":"R449","pred":"arg1Of","subj":"T437","obj":"T438"},{"id":"R450","pred":"arg2Of","subj":"T439","obj":"T438"},{"id":"R451","pred":"arg1Of","subj":"T438","obj":"T440"},{"id":"R452","pred":"arg2Of","subj":"T442","obj":"T440"},{"id":"R453","pred":"arg1Of","subj":"T442","obj":"T441"},{"id":"R454","pred":"arg1Of","subj":"T424","obj":"T443"},{"id":"R455","pred":"arg2Of","subj":"T444","obj":"T443"},{"id":"R456","pred":"arg1Of","subj":"T415","obj":"T444"},{"id":"R457","pred":"arg2Of","subj":"T447","obj":"T444"},{"id":"R458","pred":"arg1Of","subj":"T447","obj":"T445"},{"id":"R459","pred":"arg1Of","subj":"T447","obj":"T446"},{"id":"R460","pred":"arg1Of","subj":"T447","obj":"T448"},{"id":"R461","pred":"arg2Of","subj":"T450","obj":"T448"},{"id":"R462","pred":"arg1Of","subj":"T450","obj":"T449"},{"id":"R463","pred":"arg1Of","subj":"T450","obj":"T451"},{"id":"R464","pred":"arg2Of","subj":"T454","obj":"T451"},{"id":"R465","pred":"arg1Of","subj":"T454","obj":"T452"},{"id":"R466","pred":"arg1Of","subj":"T454","obj":"T453"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1221","span":{"begin":43,"end":49},"obj":"Chemical"}],"attributes":[{"id":"A1221","pred":"pubann:denotes","subj":"1221","obj":"MESH:D011134"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T333","span":{"begin":0,"end":267},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T454","span":{"begin":28,"end":31},"obj":"Body_part"}],"attributes":[{"id":"A454","pred":"fma_id","subj":"T454","obj":"http://purl.org/sig/ont/fma/fma62872"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T333","span":{"begin":0,"end":267},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Already, engineering of the IgG Fc and its glycan has proved a potent and effective approach for increasing the clinical effectiveness, functional specificity and safety of therapeutic mAbs and is an emerging pathway to the development of the “next‐gen” therapeutics."}